Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

BroadenBio presents FGFR4 inhibitors

May 18, 2021

BeiGene discloses Bcl-2 inhibitors

May 18, 2021

Akouos develops VEGF gene therapy for the treatment of vestibular schwannoma

May 18, 2021

Galera begins dosing in phase IIb study of GC-4711 in pancreatic cancer

May 17, 2021

Rise Biopharmaceuticals initiates phase I study of RP-72 in pancreatic cancer

May 17, 2021

Kinnate Biopharma synthesizes new Raf kinase C inhibitors

May 17, 2021

SK Biopharmaceuticals divulges PRMT5 inhibitors

May 17, 2021

Phase Ib/IIa trial evaluates tigilanol tiglate with pembrolizumab in advanced melanoma

May 14, 2021

Enrollment opens in phase I/II study of BLU-945 in patients with EGFR mutant NSCLC

May 14, 2021

H. pylori oncoprotein-induced genome instability may underlie gastric cancer

May 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...